Hypothyroidism in Dogs: Symptoms, Diagnosis & Treatment

Quick Q&A

Question: What are the most common early signs of hypothyroidism in dogs that owners should watch for?

Answer: The most common early signs include unexplained weight gain without an increase in appetite, lethargy or a lack of energy, and symmetrical hair loss (often starting on the tail, giving a "rat tail" appearance). Owners may also notice their dog seeking warmth more often or developing a dull, dry coat. If you observe these signs, a veterinary consultation and baseline thyroid testing are recommended.

Introduction

Hypothyroidism is one of the most frequently diagnosed endocrine disorders in dogs, representing a common cause of metabolic slowdown in middle-aged to older canines. As a veterinary medical writer and endocrinology specialist, I have structured this pillar article to serve as an exhaustive, publication-grade reference for veterinary professionals, students, and dedicated pet owners. We will cover the full spectrum of the disease: from its underlying etiology (lymphocytic thyroiditis versus idiopathic follicular atrophy) to the nuanced clinical presentation, the critical diagnostic panel (Total T4, Free T4 by equilibrium dialysis, cTSH, and thyroglobulin autoantibodies), and the evidence-based protocols for levothyroxine (L-thyroxine) therapy and long-term monitoring.

This condition, while rarely life-threatening, significantly impacts a dog's quality of life if left untreated. A recent systematic review and meta-analysis documented the prevalence of endocrine diseases in Brazilian small-animal hospital caseloads, highlighting that hypothyroidism remains a substantial portion of clinical endocrine work [1]. Furthermore, studies have explored the overlap of hypothyroidism with other immune-mediated conditions, such as polymyositis and masticatory myositis, underscoring the systemic nature of the disease [3]. This guide will integrate findings from recent scientific literature (2024-2026) with established clinical guidelines from the American Veterinary Medical Association (AVMA), the American Animal Hospital Association (AAHA), the Canadian Veterinary Medical Association (CVMA), the Australian Veterinary Association (AVA), and the Federation of Veterinarians of Europe (FVE).

We will also address regional considerations, such as the prevalence of specific breeds in North America versus Europe and Australia, and the impact of concurrent non-thyroidal illness (euthyroid sick syndrome) on diagnostic accuracy. By the end of this article, you will have a comprehensive understanding of canine hypothyroidism, from first suspicion to successful long-term management.

Etiology and Pathophysiology

Primary Hypothyroidism: The Most Common Form

Over 95% of clinical hypothyroidism cases in dogs are primary, meaning the disease originates within the thyroid gland itself. The two predominant pathological processes are lymphocytic thyroiditis and idiopathic follicular atrophy.

Lymphocytic Thyroiditis (Immune-Mediated)

Lymphocytic thyroiditis is the most common cause of hypothyroidism in dogs, accounting for approximately 50% to 70% of cases. It is an immune-mediated condition characterized by the progressive infiltration of the thyroid gland by lymphocytes, plasma cells, and macrophages. This inflammatory process leads to the gradual destruction of thyroid follicles and the subsequent loss of functional thyroid tissue [3, 36].

The disease has a strong genetic component, with certain breeds showing a clear predisposition. Breeds at increased risk include the Doberman Pinscher, Golden Retriever, Labrador Retriever, Boxer, Cocker Spaniel, Dachshund, and Irish Setter. Recent research has also identified a nonsense variant in the thyroglobulin (TG) gene in Dwarf Rottweilers, demonstrating a genetic basis for thyroid dysfunction in specific lines [6]. The presence of circulating thyroglobulin autoantibodies (TgAA) is a hallmark of this condition, and their detection is a key component of the diagnostic panel [7, 36].

A 2024 longitudinal study by Egbert et al. tracked changes in thyroid hormone concentrations over time in dogs with autoimmune thyroiditis. They found that dogs with positive TgAA status often have normal total T4 (TT4) and thyroid-stimulating hormone (TSH) concentrations early in the disease, but these parameters progressively deteriorate over months to years [36]. This highlights the importance of screening at-risk breeds and the value of TgAA testing in identifying preclinical disease.

Idiopathic Follicular Atrophy

Idiopathic follicular atrophy is the second major cause of primary hypothyroidism, responsible for the remaining 30% to 50% of cases. In this form, the thyroid follicles are replaced by adipose (fatty) and fibrous connective tissue without a significant inflammatory component. The exact cause is unknown, but it is thought to represent a non-inflammatory degenerative process or the end-stage of a previous inflammatory insult. Unlike lymphocytic thyroiditis, there is no detectable autoimmune component (TgAA is negative), and the condition is not associated with a specific breed predisposition in the same way.

Secondary and Tertiary Hypothyroidism (Rare)

Secondary hypothyroidism results from a deficiency of thyroid-stimulating hormone (TSH) due to a pituitary gland disorder (e.g., a pituitary tumor or congenital pituitary dwarfism). Tertiary hypothyroidism is caused by a deficiency of thyrotropin-releasing hormone (TRH) from the hypothalamus. These forms are exceedingly rare in dogs. A 2025 case report described a dog with lymphocytic panhypophysitis resulting in panhypopituitarism, which included secondary hypothyroidism [20]. This case underscores that while rare, central causes of hypothyroidism must be considered when primary disease is ruled out.

Iatrogenic Hypothyroidism

Iatrogenic hypothyroidism can occur following treatment for hyperthyroidism (e.g., surgical thyroidectomy, radioactive iodine therapy, or long-term antithyroid medication). A 2026 case report documented iatrogenic goitrous hypothyroidism induced by long-term trimethoprim-sulfamethoxazole therapy in a dog [2]. This highlights that certain drugs can interfere with thyroid hormone synthesis, and clinicians should be aware of this potential side effect.

Congenital Hypothyroidism

Congenital hypothyroidism is rare but has been documented. A 2024 case report identified a novel mutation in the TPO (thyroid peroxidase) gene associated with congenital hypothyroidism in a cat, and similar genetic defects can occur in dogs [26]. Affected puppies present with disproportionate dwarfism, lethargy, and delayed development.

Clinical Manifestations: Recognizing the Signs

The clinical signs of hypothyroidism in dogs are largely due to a decrease in the basal metabolic rate. The onset is typically insidious, with signs developing slowly over months to years. Owners often attribute early changes to "old age," delaying diagnosis.

Metabolic and Systemic Signs

Weight Gain Without Polyphagia: This is one of the most classic and commonly reported signs. Dogs with hypothyroidism gain weight despite having a normal or even reduced appetite. The metabolic slowdown leads to decreased energy expenditure and increased fat deposition. A 2025 study by Huang et al. confirmed that serum cholesterol disturbances, including hypercholesterolemia, are common in dogs with hypothyroidism at the time of diagnosis [25].

Lethargy and Exercise Intolerance: Affected dogs are often described as "lazy," sleeping more, tiring easily on walks, and showing a general lack of enthusiasm. This is a direct consequence of reduced metabolic rate and decreased thermogenesis.

Cold Intolerance (Heat-Seeking Behaviour): Dogs with hypothyroidism often seek warm places (e.g., near radiators, under blankets) due to a reduced ability to maintain body temperature.

Neuromuscular Signs: In some cases, hypothyroidism can cause a peripheral neuropathy, leading to a weak, stilted gait, muscle wasting, and even megaesophagus (though this is debated). A 2025 case series described transient loss of consciousness in Boxer dogs with hypothyroidism, possibly related to bradyarrhythmias or neuromuscular weakness [11].

Dermatologic Signs (The Most Visible Clues)

The skin and coat are highly dependent on thyroid hormone for normal growth and maintenance. Dermatologic changes are often the presenting complaint.

Symmetrical, Non-Pruritic Alopecia: Hair loss is typically bilateral and symmetrical, starting on the flanks, trunk, and tail. The classic "rat tail" appearance results from alopecia of the tail tip.

Dull, Dry Coat and Seborrhea: The hair coat becomes dry, brittle, and lacks luster. The skin may be scaly (seborrhea sicca) or greasy (seborrhea oleosa). Secondary pyoderma (bacterial skin infection) and Malassezia (yeast) dermatitis are common due to the compromised skin barrier.

Hyperpigmentation and Myxedema: Chronic hypothyroidism leads to thickening of the skin (myxedema) due to the accumulation of glycosaminoglycans in the dermis. This gives the skin a doughy, non-pitting, thickened feel, particularly on the face (tragus thickening) and neck. Hyperpigmentation (darkening of the skin) often develops in areas of chronic hair loss.

Tragus Thickening: A specific and often overlooked sign is thickening of the ear pinnae (tragus). The ears may feel thickened, cool, and droopy.

Poor Wound Healing: Reduced metabolic activity impairs tissue repair.

Reproductive and Other Signs

Reproductive Effects: Hypothyroidism can interfere with the normal estrous cycle in bitches, leading to prolonged anestrus, failure to cycle, or infertility. A 2025 review by Egger et al. detailed the impact of hypothyroidism on bitch fertility and neonatal mortality [34]. In males, it can cause decreased libido and testicular atrophy. A 2025 study by Martínez-Barbitta et al. showed that L-thyroxine therapy, combined with progestin support, can help maintain pregnancy in bitches with concurrent hypothyroidism and hypoluteoidism [29].

Ocular Signs: Corneal lipidosis (lipid deposition in the cornea) can occur, leading to cloudiness. A 2024 case report described improved corneal clarity following lamellar keratectomy in a dog with ocular manifestations of hypothyroidism [38].

Cardiovascular Signs: Bradycardia (slow heart rate) is a common finding. Hypothyroidism can also contribute to atherosclerosis and, in severe cases, aortic thrombosis [37].

Gastrointestinal Signs: While less common, some dogs develop chronic constipation or, conversely, diarrhea. A 2026 study by Lecomte et al. found an association between hypoalbuminemia and altered thyroid parameters in dogs with chronic diarrhoea, suggesting that protein loss can drive TSH elevation and complicate diagnosis [13].

Breed-Specific and Regional Considerations

Certain breeds are overrepresented in different regions. For example, Golden Retrievers and Labrador Retrievers are commonly affected in North America, while the Boxer and Doberman Pinscher are frequently affected in Europe. In Australia, the prevalence of hypothyroidism in breeds like the Australian Cattle Dog and the Kelpie is also noted, though it may be less common. The AVMA and AAHA recommend breed-specific reference intervals for thyroid testing where available, as breed-related variations in baseline T4 exist.

Diagnostic Testing: The Complete Panel

Diagnosing hypothyroidism is not a single-test process. It requires a combination of clinical suspicion and a thorough laboratory panel. The "gold standard" initial diagnostic approach includes a thyroid panel consisting of Total T4 (TT4), Free T4 by equilibrium dialysis (fT4 by ED), canine thyroid-stimulating hormone (cTSH), and thyroglobulin autoantibodies (TgAA).

Total T4 (TT4)

Total T4 measures the total amount of thyroxine in the blood, including both protein-bound and free fractions. While it is a good screening test, it is highly influenced by non-thyroidal illness (NTI) and certain medications.

• Interpretation: A low TT4 concentration is suggestive but not diagnostic of hypothyroidism. A normal TT4 effectively rules out hypothyroidism in a dog with no concurrent illness.
• Limitations: TT4 can be falsely low in euthyroid dogs with NTI (euthyroid sick syndrome), in dogs receiving certain drugs (e.g., glucocorticoids, sulfonamides, phenobarbital), and in sighthounds (which have naturally lower TT4 levels).

Free T4 by Equilibrium Dialysis (fT4 by ED)

Free T4 is the biologically active fraction of thyroxine that is not bound to carrier proteins. Equilibrium dialysis is considered the gold standard for measuring fT4 because it physically separates the free hormone from the bound fraction, making it much less susceptible to interference from NTI and drug effects.

• Interpretation: A low fT4 by ED is a strong indicator of hypothyroidism. It is more sensitive and specific than TT4.
• Limitations: While more robust than TT4, fT4 by ED can still be suppressed in severe NTI. A 2025 study by Bolton et al. confirmed that fT4 measured by chemiluminescence and equilibrium dialysis is frequently below the reference interval in known euthyroid dogs with NTI syndrome [15]. Therefore, it must be interpreted in the context of the entire panel.

Canine TSH (cTSH)

TSH is a pituitary hormone that stimulates the thyroid gland to produce T4. In primary hypothyroidism, the negative feedback loop is broken: low T4 levels should trigger a compensatory increase in TSH.

• Interpretation: A high cTSH concentration in the face of low TT4 and/or fT4 is highly diagnostic for primary hypothyroidism.
• Limitations: Up to 20-30% of dogs with confirmed primary hypothyroidism will have a normal cTSH concentration. This can occur due to concurrent NTI, pituitary exhaustion, or the pulsatile nature of TSH secretion. Therefore, a normal TSH does not rule out hypothyroidism.

Thyroglobulin Autoantibodies (TgAA)

TgAA are antibodies directed against thyroglobulin, a protein precursor of thyroid hormone. Their presence confirms an active autoimmune process (lymphocytic thyroiditis).

• Interpretation: A positive TgAA test is diagnostic for autoimmune thyroiditis. It is a valuable marker for early or preclinical disease, as TgAA can be elevated months to years before T4 and TSH levels become abnormal [36].
• Clinical Use: TgAA testing is recommended for screening at-risk breeds and for confirming the etiology of hypothyroidism. A 2026 study by Emming et al. evaluated TgAA in dogs at the time of diagnosis of hypoadrenocorticism and during treatment, finding that TgAA status can change over time [7].

The Diagnostic Algorithm

1. Clinical Suspicion: Based on history and physical exam (weight gain, lethargy, alopecia, etc.).
2. Screening: A baseline TT4 can be used as a first step. If TT4 is normal and clinical suspicion is low, hypothyroidism is unlikely. If TT4 is low or clinical suspicion is high, proceed to a full thyroid panel.
3. Full Panel: Submit a single blood sample for TT4, fT4 by ED, cTSH, and TgAA.
4. Interpretation:
   • Classic Hypothyroidism: Low TT4, low fT4 by ED, high cTSH. TgAA may be positive or negative.
   • Autoimmune Thyroiditis: Low TT4, low fT4 by ED, normal or high cTSH, positive TgAA.
   • Euthyroid Sick Syndrome: Low TT4, low or normal fT4 by ED, normal cTSH, negative TgAA. The dog is clinically euthyroid, and the low T4 is due to NTI.
   • Subclinical Hypothyroidism: Normal TT4 and fT4, but high cTSH and/or positive TgAA. This indicates early thyroid failure. These dogs may or may not be clinically symptomatic.

False Positives and Euthyroid Sick Syndrome

The most significant diagnostic challenge is distinguishing true hypothyroidism from euthyroid sick syndrome (NTI). Any systemic illness (e.g., renal disease, liver disease, diabetes mellitus, hyperadrenocorticism, infection, inflammation) can suppress the hypothalamic-pituitary-thyroid axis, leading to low TT4 and, in severe cases, low fT4 by ED. A 2024 study by Corsini et al. examined changes in thyroid hormones during acute NTI and recovery, showing that TT4 and T3 can drop dramatically during illness and return to normal upon recovery [40].

Key Differentiators:

• cTSH: In NTI, cTSH is typically normal or low, not elevated. An elevated cTSH strongly supports true hypothyroidism.
• TgAA: Positive TgAA confirms an autoimmune process, ruling out simple NTI.
• Clinical Response: If the dog is clinically euthyroid and the lab abnormalities are mild, it is often best to treat the primary illness and recheck thyroid function after recovery.

Treatment: Levothyroxine (L-Thyroxine) Therapy

The standard of care for hypothyroidism in dogs is lifelong replacement therapy with synthetic levothyroxine (L-thyroxine). The goal is to restore euthyroid status, alleviate clinical signs, and improve quality of life.

Dosing Protocols

• Initial Dose: The typical starting dose is 0.02 mg/kg (20 mcg/kg) orally twice daily (BID). For most dogs, this translates to 0.5 to 0.8 mg BID for a 25 kg dog.
• Formulations: Levothyroxine is available as human generic tablets (e.g., 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg, 0.8 mg) and veterinary-specific formulations (e.g., Soloxine, Thyro-Tabs). Veterinary formulations are preferred for consistency and dose accuracy.
• Administration: Tablets should be given on an empty stomach (at least 1 hour before or 2 hours after feeding) to ensure consistent absorption. Food can significantly reduce absorption.

Therapeutic Monitoring

Monitoring is essential to ensure the dose is correct and to avoid iatrogenic hyperthyroidism. The standard protocol involves measuring T4 levels after a period of stabilization (typically 4-6 weeks after starting therapy or a dose change).

Peak vs. Trough T4 Levels:

• Trough T4: A blood sample is taken just before the next dose (i.e., 12 hours after the last dose for BID dosing). The goal is to have the trough T4 within the low-normal to mid-normal reference range (typically 15-30 nmol/L or 1.5-3.0 mcg/dL). This ensures the dog is not hypothyroid at the end of the dosing interval.
• Peak T4: A blood sample is taken 4-6 hours after the morning dose. The goal is to have the peak T4 at the high end of the normal range or slightly above (typically 30-50 nmol/L or 3.0-5.0 mcg/dL), but not so high as to cause hyperthyroidism.

Monitoring Protocol:

1. First Recheck (4-6 weeks): Measure peak and trough T4. Adjust dose if needed.
2. Second Recheck (3-6 months): Once the dose is stable, repeat the panel.
3. Annual Monitoring: After stabilization, annual monitoring of T4 levels and clinical signs is recommended. A full thyroid panel (including TSH and TgAA) may be repeated every 1-2 years to assess disease progression.

Adjusting the Dose

• Underdosing: If clinical signs persist and T4 levels are low, increase the dose by 10-25%.
• Overdosing: If clinical signs of hyperthyroidism develop (e.g., polyphagia, weight loss, hyperactivity, tachycardia, panting) or T4 levels are excessively high, reduce the dose by 10-25%.
• Concurrent Medications: Glucocorticoids, phenobarbital, and sulfonamides can interfere with thyroid hormone metabolism and may require higher levothyroxine doses.

Long-Term Prognosis and Safety

The prognosis for dogs with hypothyroidism is excellent with appropriate treatment. Clinical signs typically resolve within 4-8 weeks:

• Energy levels improve within 1-2 weeks.
• Weight loss occurs over 4-8 weeks.
• Hair regrowth is the slowest, often taking 2-4 months or longer.

A 2025 study by Zhu et al. examined the redox status of biomarkers in the serum of dogs with hypothyroidism and found that levothyroxine therapy helped normalize oxidative stress markers [21]. This suggests that treatment has beneficial effects beyond simply replacing hormone levels.

Long-term Safety: Levothyroxine is very safe when used at appropriate doses. Overdosing can cause iatrogenic hyperthyroidism, which can lead to cardiac issues (tachycardia, hypertension, arrhythmias) and weight loss. A 2024 case report described the development of scales in a dog after levothyroxine treatment, which resolved with dose adjustment [31]. Rarely, dogs may develop resistance to therapy, requiring higher doses.

Special Considerations

• Pregnancy and Lactation: Hypothyroidism must be carefully managed in breeding bitches. A 2025 study by Martínez-Barbitta et al. showed that L-thyroxine therapy, combined with progestin support, can help maintain pregnancy in bitches with concurrent hypothyroidism and hypoluteoidism [29]. The dose may need to be adjusted during pregnancy. The AVMA and AAHA recommend close monitoring of thyroid function in pregnant bitches.
• Concurrent Hypoadrenocorticism (Addison's Disease): Hypothyroidism can occur concurrently with hypoadrenocorticism (autoimmune polyglandular syndrome). A 2025 study by Sieber-Ruckstuhl et al. assessed thyroid function in dogs with hypoadrenocorticism, finding that some dogs develop thyroid autoantibodies over time [32]. If both conditions are present, hypoadrenocorticism must be treated first, as levothyroxine therapy can precipitate an adrenal crisis in an untreated Addisonian dog.
• Gallbladder Mucoceles: There is a known association between hypothyroidism and the formation of gallbladder mucoceles. A 2025 study by Jana-Pitre et al. found an increased risk of gallbladder rupture and death in small-breed dogs with concurrent hypothyroidism undergoing cholecystectomy [22]. The AVMA and AAHA recommend screening for gallbladder disease in hypothyroid dogs.

Regional and Breed-Specific Considerations

North America (US and Canada)

In North America, hypothyroidism is most commonly diagnosed in medium-to-large breed dogs such as Golden Retrievers, Labrador Retrievers, Doberman Pinschers, and Boxers. The AVMA and AAHA provide clear guidelines for diagnosis and management. The CVMA echoes these recommendations for Canadian veterinarians. The prevalence of tick-borne diseases (e.g., Lyme disease) in certain regions can cause NTI and complicate diagnosis.

Europe

In Europe, the FVE and the European Medicines Agency (EMA) provide oversight on veterinary medicines, including levothyroxine formulations. Breed predispositions are similar, though the Boxer and Doberman Pinscher are particularly common in the UK and Germany. The use of human generic levothyroxine is common, but veterinary-specific products are also available.

Australia

In Australia, the AVA and the Department of Agriculture, Fisheries and Forestry (DAFF) regulate veterinary medicines. The prevalence of hypothyroidism may be slightly lower in some breeds due to different genetic lines. The Australian climate (heat) can sometimes mask cold intolerance. Regional differences in tick species (e.g., paralysis tick) can cause NTI and complicate diagnosis.

Differential Diagnoses

When a dog presents with weight gain, lethargy, and hair loss, several other conditions must be considered:

• Hyperadrenocorticism (Cushing's Disease): Causes weight gain, hair loss, and lethargy, but also features polyuria/polydipsia, pot-bellied appearance, and thin skin. A low-dose dexamethasone suppression test or ACTH stimulation test differentiates it.
• Alopecia X (Growth Hormone-Responsive Alopecia): A non-inflammatory alopecia seen in Nordic breeds (e.g., Pomeranian, Chow Chow). Dogs are otherwise healthy. Thyroid panel is normal.
• Sex Hormone Imbalances: In intact dogs, testicular or ovarian tumors can cause hair loss. Thyroid panel is normal.
• Chronic Kidney Disease (CKD): Causes weight loss, lethargy, and poor coat. Differentiated by elevated creatinine and BUN.
• Severe Systemic Illness: Any chronic disease can cause NTI and mimic hypothyroidism.

Prevention and Screening

While hypothyroidism cannot be prevented in genetically predisposed dogs, early detection can improve outcomes.

• Breed Screening: For at-risk breeds (e.g., Doberman Pinscher, Golden Retriever), annual screening with a full thyroid panel (TT4, fT4 by ED, cTSH, TgAA) is recommended by the AAHA and AVMA. Early detection of TgAA positivity allows for monitoring and early intervention.
• Avoiding Iatrogenic Causes: Be cautious with long-term use of drugs known to affect thyroid function (e.g., sulfonamides, glucocorticoids, phenobarbital). If these drugs are necessary, monitor thyroid function periodically.
• Healthy Lifestyle: Maintaining a healthy weight and managing concurrent illnesses can reduce the impact of NTI on thyroid function.

Red Flags: When to Seek Immediate Veterinary Care

While hypothyroidism is a chronic, slowly progressive disease, certain complications require urgent attention:

• Sudden Collapse or Weakness: Could indicate a cardiac arrhythmia (bradycardia) or, in severe cases, aortic thrombosis [37].
• Acute Abdominal Pain or Vomiting: In a hypothyroid dog, this could signal gallbladder rupture secondary to a mucocele [22, 23].
• Signs of Iatrogenic Hyperthyroidism: If a dog on levothyroxine develops polyphagia, weight loss, hyperactivity, panting, or tachycardia, the dose may be too high and should be adjusted immediately.
• Difficulty Breathing: Could indicate megaesophagus or aspiration pneumonia, though this is rare.

Conclusion

Hypothyroidism in dogs is a common, manageable endocrine disorder that, when properly diagnosed and treated, carries an excellent prognosis. The key to successful management lies in a thorough diagnostic approach that distinguishes true hypothyroidism from euthyroid sick syndrome, followed by precise levothyroxine dosing and regular therapeutic monitoring. By understanding the underlying etiology (lymphocytic thyroiditis vs. idiopathic atrophy), recognizing the classic clinical signs (weight gain, lethargy, rat tail alopecia, tragus thickening), and utilizing the complete diagnostic panel (TT4, fT4 by ED, cTSH, TgAA), veterinary professionals can provide optimal care for affected dogs. Pet owners should be educated on the importance of lifelong therapy and regular rechecks to ensure their dog lives a long, healthy, and active life.

References

[1] de Carvalho MLP, Caragelasco DS, Librais GNM, et al. Endocrine diseases in Brazilian small-animal hospitals and referral caseloads: A systematic review and meta-analysis of proportions. Open Vet J. 2026. PMID: 42375456.

[2] Ljubez A, Preldžić D, Čamo D. Iatrogenic goitrous hypothyroidism induced by long-term trimethoprim-sulfamethoxazole therapy in a dog: A case report. Open Vet J. 2026. PMID: 42375279.

[3] Crawford-Jennings MI, Moreno RC, Shelton GD, et al. Case Report: Overlap syndrome with concurrent polymyositis, masticatory myositis, and lymphocytic thyroiditis in a dog. Front Vet Sci. 2026. PMID: 42328063.

[4] Balogh O. When physiology fails: Endocrine and clinical perspectives on complicated pregnancy and parturition outcomes in dogs. J Reprod Dev. 2026. PMID: 42309750.

[5] Salazar Borbón JD, Xu Carranza D, Alvarez Aguilar PA, et al. Price of a Dog Bite: Multiorgan Failure Secondary to Capnocytophaga canimorsus Infection Requiring Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) Support. Cureus. 2026. PMID: 42299181.

[6] Abitbol M, Drögemüller M, Schwarz C, et al. TG Nonsense Variant in Dwarf Rottweiler Dogs. Anim Genet. 2026. PMID: 42173671.

[7] Emming C, Strey S, Leiter I, et al. Evaluation of thyroglobulin autoantibodies in dogs at the time of diagnosis of hypoadrenocorticism and during treatment. Vet Rec. 2026. PMID: 42050858.

[8] Castonguay-Poirier M, Fifle L, Javard R, et al. Long-term safety and efficacy of oral bezafibrate use in dogs with hypertriglyceridemia. J Vet Intern Med. 2026. PMID: 41818730.

[9] Dinkel L, Keiner M. [Bacterial cholecystitis with concurrent hypothyroidism in a mixed-breed dog]. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2026. PMID: 41688130.

[10] da Silva Mattos MPL, Stolf LC, Carneiro RK. Ultrasonographic and computed tomographic findings of an intra-abdominal lipoma in a dog. Vet Res Commun. 2026. PMID: 41557112.

[11] Broome HAO, Hodgkiss-Geere H, Pereira YM, et al. Transient loss of consciousness in boxer dogs with hypothyroidism: 3 cases (2015-2018). BMC Vet Res. 2025. PMID: 41398279.

[12] Cobucci GC, Teyssandier S, Tavares FM, et al. Spontaneous adult-onset primary hypothyroidism in 17 cats. J Feline Med Surg. 2026. PMID: 41395771.

[13] Lecomte A, Baudry M, Boucher D, et al. Hypoalbuminemia and altered thyroid parameters in dogs with chronic diarrhoea: Is protein loss driving TSH elevation? Vet J. 2026. PMID: 41308863.

[14] Hashemi S, Shomali T, Derakhshandeh N, et al. Effect of vitamin D3 supplementation on thyroid function of clinically healthy dogs. Front Vet Sci. 2025. PMID: 41142562.

[15] Bolton TA, Marino CL, Derré MG, et al. Free thyroxine measured by chemiluminescence and equilibrium dialysis is frequently below the reference interval in known euthyroid dogs with nonthyroidal illness syndrome. Front Vet Sci. 2025. PMID: 41142555.

[16] Al Dulaimi QA, Sabaneh NK, Ajeka S. Laparoscopic Management of a Giant Echinococcal Liver Hydatid Cyst in a Technically Challenging Site With Simultaneous Ureteric Stone Removal: A Case Report. Cureus. 2025. PMID: 41089113.

[17] Oberbauer AM, Belanger JM, Petroff BK, et al. Repeated thyroid function evaluations in the dog: a retrospective study of 8,309 dogs. Front Vet Sci. 2025. PMID: 41030683.

[18] Strey S, Leiter I, Mischke R, et al. [Evaluation of endogenous aldosterone concentrations and thyroid parameters in dogs with hypoadrenocorticism - a pilot study]. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2025. PMID: 40897179.

[19] Elgalfy GE, Ghanem MM, Helal MAY, et al. Incidence, complications and therapeutic evaluation of clinical hypothyroidism in different breeds of dogs. BMC Vet Res. 2025. PMID: 40346543.

[20] David M, Olender M, Fritz J, et al. Lymphocytic Panhypophysitis Resulting in Panhypopituitarism in a Dog. J Am Anim Hosp Assoc. 2025. PMID: 40304444.

[21] Zhu L, Han J, Bahetijiang H, et al. Redox status of biomarkers in serum of dogs with hypothyroidism and its treatment with levothyroxine sodium. Front Vet Sci. 2025. PMID: 40256603.

[22] Jana-Pitre K, Hennig GS. Increased risk of gallbladder rupture and death in small-breed dogs with concurrent hypothyroidism or pancreatitis undergoing cholecystectomy for gallbladder mucoceles. Can J Vet Res. 2025. PMID: 40170913.

[23] Gookin JL, Mathews KG, Seiler G. Diagnosis and management of gallbladder mucocele formation in dogs. J Am Vet Med Assoc. 2025. PMID: 40107232.

[24] Sasso R, Siniscalchi M, d'Ingeo S, et al. Correlations of Free Thyroid Hormones Measured by Tandem Mass Spectrometry and Immunoassay in Dogs. Animals (Basel). 2025. PMID: 40075972.

[25] Huang W, Paulin MV, Snead ECR. Serum cholesterol disturbances in dogs with common endocrinopathies at the time of diagnosis: a retrospective study. BMC Vet Res. 2025. PMID: 40033334.

[26] Gallego-Munevar C, Carrillo-Godoy N, Rondón-Barragán IS. Molecular detection of a novel mutation in the TPO gene associated with congenital hypothyroidism in a cat: Case report. J Adv Vet Anim Res. 2024. PMID: 40013294.

[27] Mantziaras G, Zakosek Pipan M. "My Bitch Is Empty!" An Overview of the Reasons for Pregnancy Loss in Dogs. Vet Sci. 2025. PMID: 40005887.

[28] MacMillan KM, Burns JJ, John E, et al. The occurrence of low thyroxine concentrations and response to thyrotropin-releasing hormone using equine and canine assays in a population of Standardbred racehorses in Prince Edward Island, Canada. J Equine Vet Sci. 2025. PMID: 39988186.

[29] Martínez-Barbitta M, Crusco SE, Goga BC, et al. L-thyroxine and 4-pregnane-3,20‑dione preserves pregnancy in bitches with hypothyroidism and hypoluteoidism. Domest Anim Endocrinol. 2025. PMID: 39954535.

[30] Choi K. A Pilot Study of the Total Cholesterol/High-Density Lipoprotein Ratio as a Prognostic Indicator of Hyperlipidemia-Related Diseases in Dogs and Cats. Curr Issues Mol Biol. 2024. PMID: 39590316.

[31] Kasuga Y, Murayama N. Scales in a dog after levothyroxine sodium treatment: A case report. Open Vet J. 2024. PMID: 39545197.

[32] Sieber-Ruckstuhl NS, Riond B, Fracassi F, et al. Longitudinal assessment of thyroid function in dogs with hypoadrenocorticism: Clinical outcomes and prevalence of autoantibodies. J Vet Intern Med. 2025. PMID: 39531378.

[33] Kang JH, Noh MY, Yoon HY. Intrahepatic Duct Incision and Closure for the Treatment of Multiple Cholelithiasis in a Dog. Vet Sci. 2024. PMID: 39195832.

[34] Egger R, Conze T, Wehrend A. [Impact of hypothyroidism on bitch fertility and neonatal mortality and morbidity - a review of the literature]. *